Barclays
TMCI icon

Barclays’s Treace Medical Concepts TMCI Stock Holding History

Barclays’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
51,630
+15,194
+42% +$41.8K ﹤0.01% 3681
2026
Q1 		$43.7K Sell
36,436
-51,228
-58% -$102K ﹤0.01% 4372
2025
Q4 		$215K Buy
87,664
+6,077
+7% +$26.4K ﹤0.01% 4272
2025
Q3 		$547K Sell
81,587
-18,704
-19% -$122K ﹤0.01% 3754
2025
Q2 		$590K Buy
100,291
+47,228
+89% +$308K ﹤0.01% 3665
2025
Q1 		$445K Sell
53,063
-24,222
-31% -$218K ﹤0.01% 3604
2024
Q4 		$539K Sell
77,285
-2,411
-3% -$16.1K ﹤0.01% 3773
2024
Q3 		$460K Buy
79,696
+62,073
+352% +$399K ﹤0.01% 3834
2024
Q2 		$117K Sell
17,623
-23,423
-57% -$189K ﹤0.01% 3834
2024
Q1 		$536K Sell
41,046
-30,246
-42% -$403K ﹤0.01% 3543
2023
Q4 		$918K Buy
71,292
+54,952
+336% +$555K ﹤0.01% 3496
2023
Q3 		$199K Sell
16,340
-2,934
-15% -$53.7K ﹤0.01% 3303
2023
Q2 		$475K Buy
19,274
+653
+4% +$16.9K ﹤0.01% 2781
2023
Q1 		$479K Buy
18,621
+9,666
+108% +$227K ﹤0.01% 3297
2022
Q4 		$210K Buy
8,955
+7,541
+533% +$174K ﹤0.01% 3811
2022
Q3 		$32K Sell
1,414
-3,654
-72% -$70.7K ﹤0.01% 3920
2022
Q2 		$73K Sell
5,068
-3,282
-39% -$55.3K ﹤0.01% 3902
2022
Q1 		$157K Buy
+8,350
New +$162K ﹤0.01% 3567

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Barclays's TMCI Position: Q2 2026 in Review

Barclays increased its Treace Medical Concepts (TMCI) stake by 42% in Q2 2026, buying an estimated $41.8K and bringing the position to 51,630 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.

Barclays first reported a position in TMCI in Q1 2022 and has held it in 18 quarters since. The position peaked at $918K in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Barclays held 51,630 shares of Treace Medical Concepts worth $205K as of Q2 2026.
  • Barclays bought 15,194 Treace Medical Concepts shares in Q2 2026, an estimated $41.8K.
  • Treace Medical Concepts made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3681 holding.
  • Barclays first reported a position in Treace Medical Concepts in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Treace Medical Concepts position peaked at $918K in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.